BOLA3 and pulmonary arterial hypertension: BOLA3 downregulation promotes metabolic reprogramming of pulmonary arterial endothelial cells by regulating mitochondrial glucose metabolism and glycine homeostasis, a metabolic shift that plays a key role in the development of PAH, particularly in the clinical subtypes of type 1 and type 3 PAH [78].